;PMID: 12095979
;source_file_2993.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..61] = [t:0..61]
;1)sentence:[e:66..158] = [t:66..158]
;2)section:[e:162..208] = [t:162..208]
;3)section:[e:212..382] = [t:212..382]
;4)sentence:[e:386..534] = [t:386..534]
;5)sentence:[e:535..646] = [t:535..646]
;6)sentence:[e:647..762] = [t:647..762]
;7)sentence:[e:763..909] = [t:763..909]
;8)sentence:[e:910..1025] = [t:910..1025]
;9)sentence:[e:1026..1267] = [t:1026..1267]
;10)sentence:[e:1268..1411] = [t:1268..1411]
;11)sentence:[e:1412..1518] = [t:1412..1518]
;12)section:[e:1522..1567] = [t:1522..1567]

;section 0 Span:0..61
;J Biol Chem.  2002 Sep 20;277(38):34815-25. Epub 2002 Jul 02.
(SEC
  (FRAG (NNP:[0..1] J) (NNP:[2..6] Biol) (NNP:[7..11] Chem) (.:[11..12] .)
        (``:[14..18] 2002) (JJ:[19..22] Sep) (CD:[23..29] 20;277)
        (-LRB-:[29..30] -LRB-) (CD:[30..32] 38) (-RRB-:[32..33] -RRB-)
        (::[33..34] :) (CD:[34..38] 3481) (CD:[38..42] 5-25) (.:[42..43] .)
        (NNP:[44..48] Epub) (::[49..53] 2002) (NNP:[54..57] Jul)
        (CD:[58..60] 02) (.:[60..61] .)))

;sentence 1 Span:66..158
;The expression of the developmentally regulated proto-oncogene Pax-3 is 
;modulated by N-Myc.
;[129..134]:gene-rna:"Pax-3"
;[152..157]:gene-rna:"N-Myc"
(SENT
  (S-HLN
    (NP-SBJ-1
      (NP (DT:[66..69] The) (NN:[70..80] expression))
      (PP (IN:[81..83] of)
        (NP
          (NP (DT:[84..87] the)
            (ADJP
              (ADVP (RB:[88..103] developmentally))
              (VBN:[104..113] regulated))
            (AFX:[114..119] proto) (HYPH:[119..120] -) (NN:[120..128] oncogene))
          (NN:[129..134] Pax-3))))
    (VP (VBZ:[135..137] is)
      (VP (VBN:[139..148] modulated)
        (NP-1 (-NONE-:[148..148] *))
        (PP (IN:[149..151] by)
          (NP (NN:[152..157] N-Myc)))))
    (.:[157..158] .)))

;section 2 Span:162..208
;Harris RG, White E, Phillips ES, Lillycrop KA.
(SEC
  (FRAG (NNP:[162..168] Harris) (NNP:[169..171] RG) (,:[171..172] ,)
        (NNP:[173..178] White) (NNP:[179..180] E) (,:[180..181] ,)
        (NNP:[182..190] Phillips) (NNP:[191..193] ES) (,:[193..194] ,)
        (NNP:[195..204] Lillycrop) (NNP:[205..207] KA) (.:[207..208] .)))

;section 3 Span:212..382
;Department of Biochemistry and Molecular Biology, School of Biological
;Sciences,  University of Southampton, Bassett Crescent East, Southampton SO16
;7PX, United  Kingdom.
(SEC
  (FRAG (NNP:[212..222] Department) (IN:[223..225] of)
        (NNP:[226..238] Biochemistry) (CC:[239..242] and)
        (NNP:[243..252] Molecular) (NNP:[253..260] Biology) (,:[260..261] ,)
        (NNP:[262..268] School) (IN:[269..271] of) (NNP:[272..282] Biological)
        (NNP:[283..291] Sciences) (,:[291..292] ,) (NNP:[294..304] University)
        (IN:[305..307] of) (NNP:[308..319] Southampton) (,:[319..320] ,)
        (NNP:[321..328] Bassett) (NNP:[329..337] Crescent) (NNP:[338..342] East)
        (,:[342..343] ,) (NNP:[344..355] Southampton) (NNP:[356..360] SO16)
        (NNP:[361..364] 7PX) (,:[364..365] ,) (NNP:[366..372] United)
        (NNP:[374..381] Kingdom) (.:[381..382] .)))

;sentence 4 Span:386..534
;N-Myc is a member of the Myc family of transcription factors that have been 
;shown to play a pivotal role in cell proliferation and differentiation.
;[386..391]:gene-generic:"N-Myc"
;[411..414]:gene-generic:"Myc"
(SENT
  (S
    (NP-SBJ (NN:[386..391] N-Myc))
    (VP (VBZ:[392..394] is)
      (NP-PRD
        (NP (DT:[395..396] a) (NN:[397..403] member))
        (PP (IN:[404..406] of)
          (NP
            (NP (DT:[407..410] the) (NN:[411..414] Myc) (NN:[415..421] family))
            (PP (IN:[422..424] of)
              (NP
                (NP (NN:[425..438] transcription) (NNS:[439..446] factors))
                (SBAR
                  (WHNP-1 (WDT:[447..451] that))
                  (S
                    (NP-SBJ-1 (-NONE-:[451..451] *T*))
                    (VP (VBP:[452..456] have)
                      (VP (VBN:[457..461] been)
                        (VP (VBN:[463..468] shown)
                          (S
                            (NP-SBJ-1 (-NONE-:[468..468] *))
                            (VP (TO:[469..471] to)
                              (VP (VB:[472..476] play)
                                (NP (DT:[477..478] a) (JJ:[479..486] pivotal)
                                    (NN:[487..491] role))
                                (PP (IN:[492..494] in)
                                  (NP
                                    (NP
                                      (NML-2 (NN:[495..499] cell))
                                      (NN:[500..513] proliferation))
                                    (CC:[514..517] and)
                                    (NP
                                      (NML-2 (-NONE-:[517..517] *P*))
                                      (NN:[518..533] differentiation))))))))))))))))))
    (.:[533..534] .)))

;sentence 5 Span:535..646
;In this  report, we have investigated the relationship between N-Myc and the 
;developmental control gene Pax-3.
;[598..603]:gene-generic:"N-Myc"
;[640..645]:gene-rna:"Pax-3"
(SENT
  (S
    (PP (IN:[535..537] In)
      (NP (DT:[538..542] this) (NN:[544..550] report)))
    (,:[550..551] ,)
    (NP-SBJ-1 (PRP:[552..554] we))
    (VP (VBP:[555..559] have)
      (VP (VBN:[560..572] investigated)
        (NP-1 (-NONE-:[572..572] *))
        (NP
          (NP (DT:[573..576] the) (NN:[577..589] relationship))
          (PP (IN:[590..597] between)
            (NP
              (NP (NN:[598..603] N-Myc))
              (CC:[604..607] and)
              (NP
                (NP (DT:[608..611] the) (JJ:[613..626] developmental)
                    (NN:[627..634] control) (NN:[635..639] gene))
                (NP (NN:[640..645] Pax-3))))))))
    (.:[645..646] .)))

;sentence 6 Span:647..762
;Using transient transfection assays, we show  that the Pax-3 promoter is
;activated by both N-Myc-Max and c-Myc-Max.
;[702..707]:gene-rna:"Pax-3"
;[738..747]:gene-generic:"N-Myc-Max"
;[752..761]:gene-generic:"c-Myc-Max"
(SENT
  (S
    (S-MNR
      (NP-SBJ (-NONE-:[647..647] *))
      (VP (VBG:[647..652] Using)
        (NP (JJ:[653..662] transient) (NN:[663..675] transfection)
            (NNS:[676..682] assays))))
    (,:[682..683] ,)
    (NP-SBJ (PRP:[684..686] we))
    (VP (VBP:[687..691] show)
      (SBAR (IN:[693..697] that)
        (S
          (NP-SBJ-1 (DT:[698..701] the) (NN:[702..707] Pax-3)
                    (NN:[708..716] promoter))
          (VP (VBZ:[717..719] is)
            (VP (VBN:[720..729] activated)
              (NP-1 (-NONE-:[729..729] *))
              (PP (IN:[730..732] by)
                (NP-LGS (CC:[733..737] both) (NN:[738..747] N-Myc-Max)
                        (CC:[748..751] and) (NN:[752..761] c-Myc-Max))))))))
    (.:[761..762] .)))

;sentence 7 Span:763..909
;Moreover,  we show that Myc regulation of Pax-3 promoter activity is
;dependent upon a  noncanonical E box site in the 5' promoter region of
;Pax-3.
;[787..790]:gene-generic:"Myc"
;[805..810]:gene-rna:"Pax-3"
;[903..908]:gene-rna:"Pax-3"
(SENT
  (S
    (ADVP (RB:[763..771] Moreover))
    (,:[771..772] ,)
    (NP-SBJ (PRP:[774..776] we))
    (VP (VBP:[777..781] show)
      (SBAR (IN:[782..786] that)
        (S
          (NP-SBJ
            (NP (NN:[787..790] Myc) (NN:[791..801] regulation))
            (PP (IN:[802..804] of)
              (NP
                (NML (NN:[805..810] Pax-3) (NN:[811..819] promoter))
                (NN:[820..828] activity))))
          (VP (VBZ:[829..831] is)
            (ADJP-PRD (JJ:[832..841] dependent)
              (PP (IN:[842..846] upon)
                (NP (DT:[847..848] a) (JJ:[850..862] noncanonical)
                  (NML (NN:[863..864] E) (NN:[865..868] box))
                  (NN:[869..873] site))))
            (PP (IN:[874..876] in)
              (NP
                (NP (DT:[877..880] the)
                  (NML (CD:[881..882] 5) (SYM:[882..883] '))
                  (NN:[884..892] promoter) (NN:[893..899] region))
                (PP (IN:[900..902] of)
                  (NP (NN:[903..908] Pax-3)))))))))
    (.:[908..909] .)))

;sentence 8 Span:910..1025
;In addition, we show  that ectopic expression of both N-Myc and c-Myc leads
;to increased expression of  Pax-3 mRNA.
;[964..969]:gene-generic:"N-Myc"
;[974..979]:gene-generic:"c-Myc"
;[1014..1019]:gene-rna:"Pax-3"
(SENT
  (S
    (PP (IN:[910..912] In)
      (NP (NN:[913..921] addition)))
    (,:[921..922] ,)
    (NP-SBJ (PRP:[923..925] we))
    (VP (VBP:[926..930] show)
      (SBAR (IN:[932..936] that)
        (S
          (NP-SBJ
            (NP (JJ:[937..944] ectopic) (NN:[945..955] expression))
            (PP (IN:[956..958] of)
              (NP (CC:[959..963] both) (NN:[964..969] N-Myc) (CC:[970..973] and)
                  (NN:[974..979] c-Myc))))
          (VP (VBZ:[980..985] leads)
            (PP-CLR (TO:[986..988] to)
              (NP
                (NP (VBN:[989..998] increased) (NN:[999..1009] expression))
                (PP (IN:[1010..1012] of)
                  (NP (NN:[1014..1019] Pax-3) (NN:[1020..1024] mRNA)))))))))
    (.:[1024..1025] .)))

;sentence 9 Span:1026..1267
;Furthermore, we show that Pax-3 mRNA expression is cell  cycle-regulated and
;that the 5' promoter region of Pax-3 (bp -1578 to +56) can  direct cell
;cycle-dependent gene expression with kinetics similar to that of the 
;endogenous transcript.
;[1052..1057]:gene-rna:"Pax-3"
;[1134..1139]:gene-rna:"Pax-3"
(SENT
  (S
    (ADVP (RB:[1026..1037] Furthermore))
    (,:[1037..1038] ,)
    (NP-SBJ (PRP:[1039..1041] we))
    (VP (VBP:[1042..1046] show)
      (SBAR (IN:[1047..1051] that)
        (S
          (NP-SBJ (NN:[1052..1057] Pax-3) (NN:[1058..1062] mRNA)
                  (NN:[1063..1073] expression))
          (VP (VBZ:[1074..1076] is)
            (ADJP-PRD
              (NML (NN:[1077..1081] cell) (NN:[1083..1088] cycle))
              (HYPH:[1088..1089] -) (VBN:[1089..1098] regulated)))))
      (CC:[1099..1102] and)
      (SBAR (IN:[1103..1107] that)
        (S
          (NP-SBJ
            (NP (DT:[1108..1111] the)
              (NML (CD:[1112..1113] 5) (SYM:[1113..1114] '))
              (NN:[1115..1123] promoter) (NN:[1124..1130] region))
            (PP (IN:[1131..1133] of)
              (NP (NN:[1134..1139] Pax-3)))
            (PRN (-LRB-:[1140..1141] -LRB-)
              (NP-SBJ (NN:[1141..1143] bp))
              (NP-PRD
                (NML (SYM:[1144..1145] -) (CD:[1145..1149] 1578))
                (PP (TO:[1150..1152] to)
                  (NP (SYM:[1153..1154] +) (CD:[1154..1156] 56))))
              (-RRB-:[1156..1157] -RRB-)))
          (VP (MD:[1158..1161] can)
            (VP (VB:[1163..1169] direct)
              (NP
                (NP
                  (ADJP
                    (NML (NN:[1170..1174] cell) (NN:[1175..1180] cycle))
                    (HYPH:[1180..1181] -) (JJ:[1181..1190] dependent))
                  (NN:[1191..1195] gene) (NN:[1196..1206] expression))
                (PP (IN:[1207..1211] with)
                  (NP
                    (NP (NNS:[1212..1220] kinetics))
                    (ADJP (JJ:[1221..1228] similar)
                      (PP (TO:[1229..1231] to)
                        (NP
                          (NP (DT:[1232..1236] that))
                          (PP (IN:[1237..1239] of)
                            (NP (DT:[1240..1243] the)
                                (JJ:[1245..1255] endogenous)
                                (NN:[1256..1266] transcript))))))))))))))
    (.:[1266..1267] .)))

;sentence 10 Span:1268..1411
;Site-directed mutagenesis of the E box site within the  Pax-3 promoter
;significantly altered the pattern of expression through the cell  cycle.
;[1324..1329]:gene-rna:"Pax-3"
(SENT
  (S
    (NP-SBJ
      (NP
        (ADJP (NN:[1268..1272] Site) (HYPH:[1272..1273] -)
              (VBN:[1273..1281] directed))
        (NN:[1282..1293] mutagenesis))
      (PP (IN:[1294..1296] of)
        (NP
          (NP (DT:[1297..1300] the)
            (NML (NN:[1301..1302] E) (NN:[1303..1306] box))
            (NN:[1307..1311] site))
          (PP (IN:[1312..1318] within)
            (NP (DT:[1319..1322] the) (NN:[1324..1329] Pax-3)
                (NN:[1330..1338] promoter))))))
    (ADVP (RB:[1339..1352] significantly))
    (VP (VBD:[1353..1360] altered)
      (NP
        (NP (DT:[1361..1364] the) (NN:[1365..1372] pattern))
        (PP (IN:[1373..1375] of)
          (NP (NN:[1376..1386] expression)))
        (PP (IN:[1387..1394] through)
          (NP (DT:[1395..1398] the) (NN:[1399..1403] cell)
              (NN:[1405..1410] cycle)))))
    (.:[1410..1411] .)))

;sentence 11 Span:1412..1518
;These results suggest that the Myc family of transcription factors may 
;modulate Pax-3 expression in vivo.
;[1443..1446]:gene-generic:"Myc"
;[1493..1498]:gene-rna:"Pax-3"
(SENT
  (S
    (NP-SBJ (DT:[1412..1417] These) (NNS:[1418..1425] results))
    (VP (VBP:[1426..1433] suggest)
      (SBAR (IN:[1434..1438] that)
        (S
          (NP-SBJ
            (NP (DT:[1439..1442] the) (NN:[1443..1446] Myc)
                (NN:[1447..1453] family))
            (PP (IN:[1454..1456] of)
              (NP (NN:[1457..1470] transcription) (NNS:[1471..1478] factors))))
          (VP (MD:[1479..1482] may)
            (VP (VB:[1484..1492] modulate)
              (NP (NN:[1493..1498] Pax-3) (NN:[1499..1509] expression))
              (ADVP (FW:[1510..1512] in) (FW:[1513..1517] vivo)))))))
    (.:[1517..1518] .)))

;section 12 Span:1522..1567
;PMID: 12095979 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1522..1526] PMID) (::[1526..1527] :) (CD:[1528..1536] 12095979)
        (NN:[1537..1538] -LSB-) (NNP:[1538..1544] PubMed) (::[1545..1546] -)
        (NN:[1547..1554] indexed) (IN:[1555..1558] for)
        (NNP:[1559..1567] MEDLINE-RSB-)))
